Hims & Hers Health ( HIMS 3.08%) stock jumped 2.2% through 10:45 a.m. ET Monday after Morgan Stanley analyst Craig Hettenbach ...

周一，花旗分析师Daniel Grosslight确认了对Hims & Hers Health, Inc. (NYSE: HIMS )的卖出评级和27.00美元的目标价。Grosslight的声明针对了最近涉及药物tirzepatide的法律进展，该药物在FDA短缺清单上的地位已成为一起法院案件的主题。

We recently published a list of 15 Stocks That Outperform the S&P 500 Every Year For the Last 3 Years. In this article, we ...

旧金山讯—Hims & Hers Health, Inc.（NYSE:HIMS）报告称，公司首席会计官Irene Becklund于2025年3月11日出售了2,203股A类普通股。每股平均售价为34.77美元，交易总额为76,598美元。

Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...

格隆汇3月10日｜远程医疗公司Hims & Hers Health上周五表示，将关闭其个性化痤疮治疗皮肤科业务Apostrophe。该公司表示，关闭Apostrophe是为了将公司的皮肤科产品和运营简化为一种“无缝体验”。Hims & ...

Roller-coaster healthcare stock Hims & Hers Health ( HIMS -1.34%), whose stock got devastated last week by worries that it ...

周一，花旗分析师Daniel Grosslight确认了对Hims & Hers Health, Inc. (HIMS.US)的“卖出”评级和27.00美元的目标价。Grosslight的声明涉及药物tirzepatide的最新法律进展，该药物因其在FDA短缺名单上的地位而成为一起法庭案件的主题。

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on ...

Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...